Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Claudia Glingani and Massimo Franchini.
Claudia Glingani
Connection Strength
6.282
Massimo Franchini
  1. Measuring accuracy of the neutralizing activity of COVID-19 convalescent plasma. Clin Chem Lab Med. 2022 01 26; 60(1):e4-e6.
    View in: PubMed
    Score: 0.965
  2. Impact of pathogen reduction technology on neutralizing antibody titer in COVID-19 convalescent plasma. Transfus Clin Biol. 2022 02; 29(1):101-102.
    View in: PubMed
    Score: 0.959
  3. Safety of Convalescent Plasma Transfusion. Mayo Clin Proc. 2021 05; 96(5):1368-1369.
    View in: PubMed
    Score: 0.943
  4. Lack of cross-reactivity between anti-A IgG isoagglutinins and anti-SARS-CoV-2 IgG antibodies. Clin Chem Lab Med. 2021 Jun 25; 59(7):e279-e281.
    View in: PubMed
    Score: 0.929
  5. Dynamics of anti-SARS-CoV-2 antibodies in repeat convalescent plasma donors. Transfus Apher Sci. 2021 12; 60(6):103216.
    View in: PubMed
    Score: 0.239
  6. Convalescent Plasma for Pregnant Women with COVID-19: A Systematic Literature Review. Viruses. 2021 06 22; 13(7).
    View in: PubMed
    Score: 0.238
  7. Early and persistent viral clearance in COVID-19 patients treated with convalescent plasma. Transfus Clin Biol. 2021 08; 28(3):309-310.
    View in: PubMed
    Score: 0.235
  8. The Three Pillars of COVID-19 Convalescent Plasma Therapy. Life (Basel). 2021 Apr 18; 11(4).
    View in: PubMed
    Score: 0.235
  9. Cerebral venous thrombosis and thrombocytopenia post-COVID-19 vaccination. Thromb Res. 2021 06; 202:182-183.
    View in: PubMed
    Score: 0.235
  10. Potential mechanisms of action of convalescent plasma in COVID-19. Diagnosis (Berl). 2021 11 25; 8(4):413-420.
    View in: PubMed
    Score: 0.233
  11. Safety and Efficacy of Convalescent Plasma in Elderly COVID-19 Patients: The RESCUE Trial. Mayo Clin Proc Innov Qual Outcomes. 2021 Apr; 5(2):403-412.
    View in: PubMed
    Score: 0.232
  12. The protective effect of O blood type against SARS-CoV-2 infection. Vox Sang. 2021 02; 116(2):249-250.
    View in: PubMed
    Score: 0.226
  13. Challenges in the Production of Convalescent Hyperimmune Plasma in the Age of COVID-19. Semin Thromb Hemost. 2020 10; 46(7):804-806.
    View in: PubMed
    Score: 0.222
  14. The first case of acquired hemophilia A associated with SARS-CoV-2 infection. Am J Hematol. 2020 08; 95(8):E197-E198.
    View in: PubMed
    Score: 0.221
  15. A retrospective study assessing the characteristics of COVID-19 convalescent plasma donors and donations. Transfusion. 2021 03; 61(3):830-838.
    View in: PubMed
    Score: 0.057
  16. Mortality reduction in 46 severe Covid-19 patients treated with hyperimmune plasma. A proof of concept single arm multicenter trial. Haematologica. 2020 12 01; 105(12):2834-2840.
    View in: PubMed
    Score: 0.057
  17. Convalescent plasma for coronavirus disease 2019 in pregnancy: a case report and review. Am J Obstet Gynecol MFM. 2020 08; 2(3):100174.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.